Author
Listed:
- Bo Heinemann
(EpiTherapeutics Aps, Ole Maaløes Vej 3, 2200 Copenhagen, Denmark)
- Jesper Morten Nielsen
(EpiTherapeutics Aps, Ole Maaløes Vej 3, 2200 Copenhagen, Denmark)
- Heidi Rye Hudlebusch
(EpiTherapeutics Aps, Ole Maaløes Vej 3, 2200 Copenhagen, Denmark)
- Michael J. Lees
(Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Ole Maaløes Vej 5, 2200 Copenhagen, Denmark)
- Dorthe Vang Larsen
(EpiTherapeutics Aps, Ole Maaløes Vej 3, 2200 Copenhagen, Denmark)
- Thomas Boesen
(EpiTherapeutics Aps, Ole Maaløes Vej 3, 2200 Copenhagen, Denmark)
- Marc Labelle
(EpiTherapeutics Aps, Ole Maaløes Vej 3, 2200 Copenhagen, Denmark)
- Lars-Ole Gerlach
(EpiTherapeutics Aps, Ole Maaløes Vej 3, 2200 Copenhagen, Denmark)
- Peter Birk
(EpiTherapeutics Aps, Ole Maaløes Vej 3, 2200 Copenhagen, Denmark)
- Kristian Helin
(Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Ole Maaløes Vej 5, 2200 Copenhagen, Denmark
Centre for Epigenetics, University of Copenhagen, Ole Maaløes Vej 5, 2200 Copenhagen, Denmark
The Danish Stem Cell Center (DanStem), University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen, Denmark)
Abstract
Arising from L. Kruidenier et al. Nature 488, 404–408 (2012); doi:10.1038/nature11262 The recent publication1 of the first highly potent and specific inhibitor GSK-J1/J4 of the H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A provides a potential tool compound for this histone demethylase subfamily1. This inhibitor was used in tissue culture assays to conclude that the catalytic activities of the KDM6 proteins are required in inflammatory responses1; the generation of the inhibitor is intriguing, because it provides a strategy for generating sub-type-specific inhibitors of the 27-member Jumonji family and for the future treatment of various types of disease2,3,4,5,6. Here we show that the inhibitor is not specific for the H3K27me3/me2-demethylase subfamily in vitro and in tissue culture assays. Thus, the inhibitor cannot be used alone for drawing conclusions regarding the specific role of H3K27me3/me2-demethylase activity in biological processes or disease. There is a Reply to this Brief Communications Arising by Kruidenier et al. Nature 514, http://dx.doi.org/10.1038/nature13689 (2014).
Suggested Citation
Bo Heinemann & Jesper Morten Nielsen & Heidi Rye Hudlebusch & Michael J. Lees & Dorthe Vang Larsen & Thomas Boesen & Marc Labelle & Lars-Ole Gerlach & Peter Birk & Kristian Helin, 2014.
"Inhibition of demethylases by GSK-J1/J4,"
Nature, Nature, vol. 514(7520), pages 1-2, October.
Handle:
RePEc:nat:nature:v:514:y:2014:i:7520:d:10.1038_nature13688
DOI: 10.1038/nature13688
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:514:y:2014:i:7520:d:10.1038_nature13688. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.